JP4881526B2 - 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 - Google Patents
牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 Download PDFInfo
- Publication number
- JP4881526B2 JP4881526B2 JP2001533813A JP2001533813A JP4881526B2 JP 4881526 B2 JP4881526 B2 JP 4881526B2 JP 2001533813 A JP2001533813 A JP 2001533813A JP 2001533813 A JP2001533813 A JP 2001533813A JP 4881526 B2 JP4881526 B2 JP 4881526B2
- Authority
- JP
- Japan
- Prior art keywords
- phl
- rphl
- allergen
- ige
- grass pollen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000013566 allergen Substances 0.000 title claims abstract description 61
- 229940046528 grass pollen Drugs 0.000 title description 44
- 230000002163 immunogen Effects 0.000 claims abstract description 17
- 230000000774 hypoallergenic effect Effects 0.000 claims abstract description 12
- 238000003745 diagnosis Methods 0.000 claims abstract description 4
- 206010020751 Hypersensitivity Diseases 0.000 claims description 12
- 208000026935 allergic disease Diseases 0.000 claims description 12
- 230000007815 allergy Effects 0.000 claims description 11
- 238000000586 desensitisation Methods 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 2
- 238000001727 in vivo Methods 0.000 claims description 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 230000036039 immunity Effects 0.000 claims 1
- 238000012217 deletion Methods 0.000 abstract description 25
- 230000037430 deletion Effects 0.000 abstract description 25
- 210000004899 c-terminal region Anatomy 0.000 abstract description 7
- 239000000203 mixture Substances 0.000 abstract description 2
- 230000000172 allergic effect Effects 0.000 description 39
- 208000010668 atopic eczema Diseases 0.000 description 39
- 241000283973 Oryctolagus cuniculus Species 0.000 description 37
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 36
- 108090000623 proteins and genes Proteins 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 29
- 102000004169 proteins and genes Human genes 0.000 description 29
- 241000746983 Phleum pratense Species 0.000 description 25
- 229960004784 allergens Drugs 0.000 description 24
- 239000013574 grass pollen allergen Substances 0.000 description 22
- 239000002245 particle Substances 0.000 description 20
- 239000012634 fragment Substances 0.000 description 19
- 229960001340 histamine Drugs 0.000 description 18
- 210000002966 serum Anatomy 0.000 description 16
- 230000009257 reactivity Effects 0.000 description 13
- 239000000020 Nitrocellulose Substances 0.000 description 10
- 239000002299 complementary DNA Substances 0.000 description 10
- 229920001220 nitrocellulos Polymers 0.000 description 10
- 150000001413 amino acids Chemical class 0.000 description 9
- 102000001708 Protein Isoforms Human genes 0.000 description 8
- 108010029485 Protein Isoforms Proteins 0.000 description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 230000002052 anaphylactic effect Effects 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000009169 immunotherapy Methods 0.000 description 8
- 241000588724 Escherichia coli Species 0.000 description 7
- 210000003651 basophil Anatomy 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 244000025254 Cannabis sativa Species 0.000 description 6
- 210000001744 T-lymphocyte Anatomy 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 238000002983 circular dichroism Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 241000283074 Equus asinus Species 0.000 description 5
- 102000011195 Profilin Human genes 0.000 description 5
- 108050001408 Profilin Proteins 0.000 description 5
- 206010040914 Skin reaction Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 230000035483 skin reaction Effects 0.000 description 5
- 231100000430 skin reaction Toxicity 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000004925 denaturation Methods 0.000 description 4
- 230000036425 denaturation Effects 0.000 description 4
- 210000003714 granulocyte Anatomy 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 210000004379 membrane Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000000523 sample Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229940030577 timothy grass pollen extract Drugs 0.000 description 4
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 3
- 206010003645 Atopy Diseases 0.000 description 3
- 108010054576 Deoxyribonuclease EcoRI Proteins 0.000 description 3
- 238000002965 ELISA Methods 0.000 description 3
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 3
- 206010048908 Seasonal allergy Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000005867 T cell response Effects 0.000 description 3
- 208000024780 Urticaria Diseases 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 238000000376 autoradiography Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 238000001142 circular dichroism spectrum Methods 0.000 description 3
- 230000009260 cross reactivity Effects 0.000 description 3
- 231100000673 dose–response relationship Toxicity 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 230000001939 inductive effect Effects 0.000 description 3
- 239000013573 pollen allergen Substances 0.000 description 3
- 201000004338 pollen allergy Diseases 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 125000001433 C-terminal amino-acid group Chemical group 0.000 description 2
- 101800004637 Communis Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 210000000712 G cell Anatomy 0.000 description 2
- 241000282821 Hippopotamus Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 240000004296 Lolium perenne Species 0.000 description 2
- 230000004988 N-glycosylation Effects 0.000 description 2
- 241000746981 Phleum Species 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- 101710127735 Pollen allergen Phl p 6 Proteins 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 108010076504 Protein Sorting Signals Proteins 0.000 description 2
- 244000082988 Secale cereale Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 229920002684 Sepharose Polymers 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 201000009961 allergic asthma Diseases 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 2
- 108010005774 beta-Galactosidase Proteins 0.000 description 2
- 230000008827 biological function Effects 0.000 description 2
- 230000037029 cross reaction Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000012636 effector Substances 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 210000003630 histaminocyte Anatomy 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 210000002706 plastid Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 238000002864 sequence alignment Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 241000238876 Acari Species 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 102000008130 Cyclic AMP-Dependent Protein Kinases Human genes 0.000 description 1
- 108010049894 Cyclic AMP-Dependent Protein Kinases Proteins 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- 241000218657 Picea Species 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 101001086866 Sus scrofa Pulmonary surfactant-associated protein B Proteins 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000011210 chromatographic step Methods 0.000 description 1
- 238000000978 circular dichroism spectroscopy Methods 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000013154 diagnostic monitoring Methods 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000000816 matrix-assisted laser desorption--ionisation Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 230000007498 myristoylation Effects 0.000 description 1
- 125000000449 nitro group Chemical class [O-][N+](*)=O 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000010647 peptide synthesis reaction Methods 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 238000011458 pharmacological treatment Methods 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000007198 pollen germination Effects 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 108010026466 polyproline Proteins 0.000 description 1
- 239000004175 ponceau 4R Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 229940125575 vaccine candidate Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
- A61K39/36—Allergens from pollen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9903950A SE9903950D0 (sv) | 1999-10-29 | 1999-10-29 | Non-anaphylactic forms of grass pollen allergen and their use |
| SE9903950-5 | 1999-10-29 | ||
| PCT/SE2000/002062 WO2001030816A1 (en) | 1999-10-29 | 2000-10-24 | NON-ANAPHYLACTIC FORMS OF GRASS POLLEN Ph1 p 6 ALLERGEN AND THEIR USE |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132059A Division JP2011236217A (ja) | 1999-10-29 | 2011-06-14 | 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003513023A JP2003513023A (ja) | 2003-04-08 |
| JP4881526B2 true JP4881526B2 (ja) | 2012-02-22 |
Family
ID=20417569
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001533813A Expired - Lifetime JP4881526B2 (ja) | 1999-10-29 | 2000-10-24 | 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 |
| JP2011132059A Pending JP2011236217A (ja) | 1999-10-29 | 2011-06-14 | 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011132059A Pending JP2011236217A (ja) | 1999-10-29 | 2011-06-14 | 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1224215B2 (enExample) |
| JP (2) | JP4881526B2 (enExample) |
| AT (1) | ATE302213T1 (enExample) |
| AU (1) | AU778066B2 (enExample) |
| CA (1) | CA2387260C (enExample) |
| DE (1) | DE60022069T3 (enExample) |
| DK (1) | DK1224215T4 (enExample) |
| ES (1) | ES2246904T5 (enExample) |
| SE (1) | SE9903950D0 (enExample) |
| WO (1) | WO2001030816A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT503530A1 (de) | 2006-04-28 | 2007-11-15 | Biomay Ag | Polypeptid mit allergenen eigenschaften |
| EP2042193A1 (en) | 2007-09-28 | 2009-04-01 | Biomay AG | RNA Vaccines |
| CN102811735B (zh) * | 2010-01-14 | 2015-09-09 | 默克专利股份公司 | 由于脯氨酸残基突变而具有降低的致敏性的禾本科的第6组过敏原的变异体 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998043657A2 (de) * | 1997-03-27 | 1998-10-08 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen immuntherapie, deren herstellung und verwendung |
-
1999
- 1999-10-29 SE SE9903950A patent/SE9903950D0/xx unknown
-
2000
- 2000-10-24 CA CA2387260A patent/CA2387260C/en not_active Expired - Lifetime
- 2000-10-24 AU AU13193/01A patent/AU778066B2/en not_active Expired
- 2000-10-24 AT AT00975093T patent/ATE302213T1/de active
- 2000-10-24 ES ES00975093T patent/ES2246904T5/es not_active Expired - Lifetime
- 2000-10-24 WO PCT/SE2000/002062 patent/WO2001030816A1/en not_active Ceased
- 2000-10-24 DK DK00975093.6T patent/DK1224215T4/da active
- 2000-10-24 DE DE60022069T patent/DE60022069T3/de not_active Expired - Lifetime
- 2000-10-24 JP JP2001533813A patent/JP4881526B2/ja not_active Expired - Lifetime
- 2000-10-24 EP EP00975093A patent/EP1224215B2/en not_active Expired - Lifetime
-
2011
- 2011-06-14 JP JP2011132059A patent/JP2011236217A/ja active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998043657A2 (de) * | 1997-03-27 | 1998-10-08 | Merck Patent Gmbh | Graminaenpollenallergenmutanten zur spezifischen immuntherapie, deren herstellung und verwendung |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2387260C (en) | 2015-12-08 |
| DK1224215T3 (da) | 2005-12-19 |
| EP1224215B1 (en) | 2005-08-17 |
| DE60022069D1 (de) | 2005-09-22 |
| ATE302213T1 (de) | 2005-09-15 |
| AU778066B2 (en) | 2004-11-11 |
| SE9903950D0 (sv) | 1999-10-29 |
| AU1319301A (en) | 2001-05-08 |
| EP1224215A1 (en) | 2002-07-24 |
| EP1224215B2 (en) | 2010-10-06 |
| JP2003513023A (ja) | 2003-04-08 |
| DE60022069T3 (de) | 2011-05-05 |
| CA2387260A1 (en) | 2001-05-03 |
| DE60022069T2 (de) | 2006-06-08 |
| JP2011236217A (ja) | 2011-11-24 |
| ES2246904T5 (es) | 2011-03-01 |
| ES2246904T3 (es) | 2006-03-01 |
| DK1224215T4 (da) | 2011-01-24 |
| WO2001030816A1 (en) | 2001-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vrtala et al. | Molecular, immunological, and structural characterization of Phl p 6, a major allergen and P-particle-associated protein from Timothy grass (Phleum pratense) pollen | |
| Vrtala et al. | Immunologic characterization of purified recombinant timothy grass pollen (Phleum pratense) allergens (Phl p 1, Phl p 2, Phl p 5) | |
| Ball et al. | Gain of structure and IgE epitopes by eukaryotic expression of the major Timothy grass pollen allergen, Phl p 1 | |
| US20090098167A1 (en) | PHL P 1 Allergen Derivative | |
| JP2011236217A (ja) | 牧草花粉Ｐｈｌｐ６アレルゲンの非アナフィラキシー形態及びそれらの使用 | |
| US8440200B2 (en) | Non-anaphylactic forms of grass pollen Ph1 p 6 allergen and their use | |
| JP4253122B2 (ja) | アレルゲンの非アナフィラキシー形およびその使用 | |
| Laffer et al. | Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family | |
| US7485305B2 (en) | Allergen from house-dust mites | |
| EP1317484B2 (en) | Variants of the phleum pratense phl p 1 allergenic protein | |
| WO2002020790A1 (en) | Parietaria judaica ns-ltp antigen variants, uses thereof and compositions comprising them | |
| WO1992016554A1 (en) | Protein allergens of the species cynodon dactylon | |
| EP1515988A1 (de) | Dna-sequenz und rekombinante herstellung des graspollen-allergens phl p4 | |
| EP1369483A1 (en) | Allergen from mugwort pollen | |
| JP3588615B2 (ja) | 組換えダニアレルゲン |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071010 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100706 |
|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20100924 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20101001 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110105 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110215 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20110614 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20110803 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20110920 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20111102 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20111129 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20111205 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 4881526 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20141209 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |